Antidepressant-Induced Yawning

Khawaja, Hamza; Sanjel, Avinav; Upadhyay, Ekta; Khawaja, Imran S.

doi:10.4088/pcc.20l02713

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Concerning psychiatry, yawning often occurs when feeling tired and becomes more frequent when external stimuli fail to provide alertness. This phenomenon has been linked to depression due to symptoms like disrupted sleep patterns and fatigue [3]. However, few studies have even identified yawning as a rare and unexpected side effect of certain antidepressant medications [3][4][5][6].…”

Section: Introductionmentioning

confidence: 99%

“…This phenomenon has been linked to depression due to symptoms like disrupted sleep patterns and fatigue [3]. However, few studies have even identified yawning as a rare and unexpected side effect of certain antidepressant medications [3][4][5][6]. There have been articles linking it specifically with antidepressants, including fluoxetine, paroxetine, sertraline, escitalopram, duloxetine, venlafaxine, imipramine, and clomipramine [7][8][9].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Yawning as a Rare Side Effect With Increased Escitalopram Dose: A Case Report

Sinha,

Patil,

Kotla

et al. 2024

Cureus

View full text Add to dashboard Cite

Yawning is a normal physiological process that occurs naturally in all human beings in different settings, such as hunger, drowsiness, or stress. It is typically harmless, but abnormal yawning can be seen in many medical conditions. In psychiatry, it frequently occurs in disorders like depression, insomnia, and anxiety due to disturbed sleep. It has also been observed as an adverse reaction of some drugs, like escitalopram, a selective serotonin reuptake inhibitor. Escitalopram is a widely prescribed, well-tolerated antidepressant and antianxiety drug that can induce a range of side effects, one of which is excessive yawning. Its excessive occurrence can be distressing for patients, affecting their socio-occupational functioning. Clinically, differentiating yawning induced by escitalopram treatment from that in depression can be a diagnostic hurdle. Awareness and recognition of this lesser known side effect can improve patient outcomes by allowing for timely adjustments and easing the discomfort.

show abstract